Media Thread, page-13484

from the JustStocks interview first minutes

".... we are producing Cancer Drug Data that are unlike any place in the world..."

".... and what that tells me is that our drug is quite active...."

" ... I don't wanna blind you with our science because it is brilliant..."

Now she is telling us directly that the scientific expectations have been met so far as the trial data have confirmed it. The question is, why isn't the market jumping on IMU. Normally when anyone comes out with a statement like this in their field the sp makes an upward move. When asked about the register, at 16:50 min, she mentioned the 3 US funds holding shares in IMU which is true but when we look at their % then it is still disappointing. She seems to be optimistic that the next data released will increase the sp to ensure the next Cap Raising shouldn't be a problem but looking back at the past years that is not a given at all.

So we are still in the same situation, impressive data which are ignored by the market - when looking at the sp and at the market depth. Maybe there is an ongoing hidden accumulation by bigger forces to move the about 75% retail holding into insto hands but that won't help anyone when it comes to raising at current or lower levels especially the way Hopper did the last time.

Personally I expect no significant move by US investors until a pharma partners with IMU and that is not expected before we have either a huge response rate from the CF33 ph1 higher doses or the current Azer-Cel / Bile duct pre-rego trials. That will take us to 25/26, about 18-24 months from here. Question is, will those 114m at hand plus 12m rebate and maybe 15m next year rebate be enough to get us to a deal or will they have to raise. If they have to raise at last resort we know the data wasn't compelling, if they raise by mid '25 or even by end of this year many will assume the data won't be sufficient.

To get the sp at least above 10c we either need data submitted that aren't just brilliant in LC's opinion but blow big pharmas socks off too. And that hasn't been the case so far, a completely different opinion of what " brilliant " means to LC and what it means to big pharma / US investors.

Unfortunately LC's opinion isn't cutting it anymore, show us the involvement of big pharma and we will re-start to trust her opinion of how valuable IMU's data in the real world are.

I am still holding as nothing is lost and the chances for a huge windfall are still real. But the "IF" is currently more dominant then the "WHEN" and Dory's 4.5c / 2c sp predictions can't be ruled out.

GLTA